Hafid Soualhine

Image Sarah London
Chief, National Reference Centre for Mycobacteriology

Conducts and manages research projects on the molecular mechanisms of drug resistance, new bioMarkers and vaccine for tuberculosis

Current research and/or projects

Dr. Soualhine conducts and manages research projects on molecular mechanisms of TB drug resistance; in the lab, his team applies next-generation sequencing methods to mycobacterium tuberculosis strains for public health surveillance purpose.

Research and/or project statements

  • Conducts and manages clinical research projects on the molecular mechanism of drug resistance in order to design and develop "point of care" test for rapid diagnosis and drug resistance detection
  • Develops whole genome sequencing (WGS) technologies and bioinformatics pipelines to identify Mycobacterium tuberculosis complex, rapidly predict drug resistance, and decipher new mechanism of drug resistance
  • Uses genomics, proteomics and transcriptomics to identify virulence factors in M. tuberculosis and other Mycobacteria
  • Special interest focus on Mycobacterium avium drug resistance and genetic material transfer, and M. abscessus molecular epidemiology and pathogenesis in cystic fibrosis patients

Education and awards


Postdoctoral Fellow, Division of Infectious Diseases. University of British Columbia - Vancouver, BC – Canada (2006-2007)                                                                                                

Postdoctoral Fellow, Centre de recherche du pavillon CHUL (Centre Hospitalier de l’Université Laval), Infectious Disease Centre, Québec – Canada  (2002-2005)

PhD Molecular biology, Institut Pasteur du Maroc and University Mohamed Ben Abdallah. Fes-Morocco, 2001       


Current grants:

GRDI grant, New omics approaches to tackling drug resistant tuberculosis. PI, 3 years, GRDI – Public Health Agency of Canada, Budget allowed 409,000. {2019-2022}

Research Grant Whole genome sequencing-based genotyping for molecular epidemiology of Mycobacterium bovis infection in animals and humans in Canada. Co-PI, Canadian Food Inspection Agency, Budget 25,000. {2019-2021}

Key publications

Wuzinski, M., Bak, A.K., Petkau, A., (...), Soualhine, H., Sharma, M.K.  A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data, 2019 International Journal of Mycobacteriology, 8(3), pp. 273-280.


Chakravarti, A., Soualhine, H., Sharma, M., (...), Poirier, L., Lavallée, C. Indigenous Transmission of Mycobacterium africanum in Canada: A Case Series and Cluster Analysis. 2019 Open Forum Infectious Diseases, 6(4).


Lau, A., Singh, V., Soualhine, H., Hmama, Z. Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain. 2017 Vaccine, 35(16), pp. 2060-2068. 


Spinato, J., Boivin, É., Bélanger-Trudelle, É., (...), Tremblay, C., Soualhine, H. Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012. 2016 BMC Microbiology, 16(1),164.


Robyn S. Lee · Nicolas Radomski · Jean-Francois Proulx · Ines Levade · B. Jesse Shapiro · Fiona McIntosh · Hafid Soualhine · Dick Menzies · Marcel A. Behr ·Population genomics of Mycobacterium tuberculosis in the Inuit.  Proceedings of the National Academy of Sciences 10/2015; 112(44).


Lee RS, Radomski N, Proulx JF, Manry J, McIntosh F, Desjardins F, Soualhine H, Domenech P, Reed MB, Menzies D, Behr MA.Re-emergence and Amplification of Tuberculosis in the Canadian Arctic. J Infect Dis. 2015 Jan 9. pii: jiv011. PMID: 25576599


Lévesque, S., Dufresne, P.J., Soualhine, H., (...), Lefebvre, B., Tremblay, C.  A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory, 2015  PLoS ONE, 10(12), e0144878.


Sharma, M., Thibert, L., Chedore, P., (...), Soualhine, H., Wolfe, J.  2011, Journal of Clinical Microbiology Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of mycobacterium tuberculosis., 49(12), pp. 4112-4116. 


Soualhine H., Deghmane A.E., Sun J., Mak K., Talal A., Av-Gay Y., Hmama Z. - Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol. 2007 Oct 15;179(8):5137-45. PMID: 17911599


Research facility

1015 Arlington Street
Winnipeg, MB R3E 3M4


Associated investigator at the McGill International TB centre, McGill University

Adjunct Professor, Department of Medical Microbiology, University of Manitoba



Other languages